Palbociclib Impurity 98 | CAS 1566082-34-5 - Request Quote
Palbociclib Impurity 98
| SZ CAT No: | SZ-P015131 |
| CAS No | 1566082-34-5 |
| Mol.F. | C9H12N4O2 |
| Mol.Wt. | 208.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Palbociclib Impurity 98 is chemically 1-(2-Nitropyridin-3-yl)piperazine. Palbociclib Impurity 98 is supplied with detailed characterization data compliant with regulatory guideline. Palbociclib Impurity 98 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Palbociclib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1566082-34-5
Purchase 1566082-34-5
Order 1566082-34-5
Enquire 1566082-34-5
price of 1566082-34-5
1566082-34-5 Supplier
1566082-34-5 Manufacturer
1566082-34-5 Exporter
buy high quality Palbociclib Impurity 98
Purchase Palbociclib Impurity 98
Palbociclib Impurity 98 suppliers
Palbociclib Impurity 98 manufacturers
Palbociclib Impurity 98 price
Order Palbociclib Impurity 98
Enquire Palbociclib Impurity 98
Palbociclib Impurity 98 cost
Palbociclib Impurity 98 Supplier
Palbociclib Impurity 98 Distributor
Palbociclib Impurity 98 for Method Validation
Palbociclib Reference Standard
Palbociclib Impurity 98 for ANDA Filing
Palbociclib Impurity 98 for Forced Degradation Studies
Palbociclib Impurity 98 Identification Standards
Palbociclib Impurity 98 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.